TARBP2 and cancer: De Vito and colleagues reported that TARBP2 depletion in Ewing sarcoma family tumor (ESFT) cells can promote self-renewal capacity and tumorigenesis by changing the miRNA profiles of these cells to be similar to those of ESFT cancer stem cells.